# Soleno Therapeutics to Participate in Upcoming November Conferences
Canonical URL: https://biopharmsignal.com/news/SLNO/soleno-therapeutics-to-participate-in-upcoming-november-conferences-07e3f36f
Ticker: SLNO
Company: Soleno Therapeutics
Source: Soleno Therapeutics
Published: 2025-10-28 12:00 EST
## Summary

Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel...

## Article Body
Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the following investor conferences in November:

Guggenheim Securities Healthcare Innovation Conference Presentation Date: Tuesday, November 11, 2025 at 9:00 AM ET Presentation Format: Fireside Chat Webcast: Here

Stifel 2025 Healthcare Conference Presentation Date: Wednesday, November 12, 2025 at 8:40 AM ET Presentation Format: Fireside Chat Webcast: Here

Jefferies London Healthcare Conference Presentation Date: Tuesday, November 18, 2025 at 5:00 PM GMT Presentation Format: Presentation Webcast: Here

Replays of the events will be available in the Investors section on the Company’s website at www.soleno.life .

About Soleno Therapeutics, Inc.

Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s first commercial product, VYKAT XR™ (diazoxide choline) extended-release tablets, formerly known as DCCR, is a once-daily oral treatment for hyperphagia in adults and children 4 years of age and older with Prader-Willi syndrome. For more information, please visit www.soleno.life .

Corporate Contact: Brian Ritchie LifeSci Advisors, LLC 212-915-2578
## Recent Company News
- 2026-02-26 13:00 EST — [Soleno Therapeutics Announces Retirement of James Mackaness and Appointment of Jennifer Fulk as Chief Financial Officer](https://biopharmsignal.com/news/SLNO/soleno-therapeutics-announces-retirement-of-james-mackaness-and-appointment-of-j-e189fa61) — Source: Soleno Therapeutics
- 2026-02-25 21:01 EST — [Soleno Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Update on U.S. Launch of VYKAT™ XR](https://biopharmsignal.com/news/SLNO/soleno-therapeutics-reports-fourth-quarter-and-full-year-2025-financial-results--3aca491a) — Source: Soleno Therapeutics
- 2026-02-11 13:00 EST — [Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET](https://biopharmsignal.com/news/SLNO/soleno-therapeutics-to-report-fourth-quarter-and-full-year-2025-financial-result-f5b4af5a) — Source: Soleno Therapeutics
- 2026-01-29 13:00 EST — [Soleno Therapeutics to Participate in Upcoming Conferences](https://biopharmsignal.com/news/SLNO/soleno-therapeutics-to-participate-in-upcoming-conferences-47ed2b8d) — Source: Soleno Therapeutics
- 2026-01-12 12:00 EST — [Soleno Therapeutics Announces Select Preliminary Fourth Quarter and Full-Year 2025 Results](https://biopharmsignal.com/news/SLNO/soleno-therapeutics-announces-select-preliminary-fourth-quarter-and-full-year-20-b38ae0a1) — Source: Soleno Therapeutics
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)